The Subclinical Cardiomyopathy of Friedreich's Ataxia in a Pediatric Population
Jonathan F Plehn1, Keren Hasbani1, Inez Ernst1
1Translational Medicine Branch, National Heart, Lung and Blood Institute.
Insights
Subclinical cardiomyopathy is common in pediatric Friedreich's ataxia (FA) patients. Concentric hypertrophy (CH) in FA is linked to diastolic and systolic dysfunction, indicating early cardiac issues.
Area of Science:
- Cardiology
- Pediatric Neurology
- Genetics
Background:
- Friedreich's ataxia (FA) is a rare genetic disorder.
- Subclinical cardiomyopathy in pediatric FA patients is not well-documented.
- Early identification of cardiac involvement is crucial for managing FA.
Purpose of the Study:
- To investigate the prevalence and characteristics of subclinical cardiomyopathy in pediatric FA patients.
- To assess cardiac structure and function using echocardiography (Echo) and cardiac magnetic resonance imaging (cMRI).
- To correlate cardiac findings with neurologic impairment in FA.
Main Methods:
- Cross-sectional analysis of 48 genetically confirmed FA subjects (aged 9-17 years) with moderate neurologic impairment.
- Echocardiography (Echo) and cardiac magnetic resonance imaging (cMRI) to assess left ventricular mass indexed to height (LVMI).
- Categorization of left ventricular (LV) remodeling (concentric remodeling, concentric hypertrophy, eccentric hypertrophy) based on LV wall thickness.
Main Results:
- 85% of subjects showed elevated Echo LVMI, exceeding age-based norms.
- LVMI correlated with depressed diastolic (E') and systolic (S') tissue Doppler velocities and increased LV filling pressure.
- Depressed LV relaxation (88%) and increased LV stiffness (71%) were common, despite normal ejection fraction (mean 60%).
- Concentric remodeling (40%) and concentric hypertrophy (CH) (44%) were prevalent; CH was associated with significant diastolic and systolic dysfunction.
Conclusions:
- Subclinical hypertrophic cardiomyopathy is a frequent finding in pediatric FA patients.
- Concentric hypertrophy (CH) in FA is associated with both diastolic and systolic cardiac dysfunction.
- These findings highlight the need for cardiac monitoring in pediatric FA.
Background:
Identification of a subclinical cardiomyopathy in pediatric patients with Friedreich's ataxia (FA) has not been well-described.
Methods:
We performed echocardiography (Echo), cardiac magnetic resonance imaging (cMRI), and neurologic assessment in a cross-sectional analysis of 48 genetically confirmed FA subjects aged 9-17 years with moderate neurologic impairment but without a cardiovascular history. Echo- and cMRI-determined left ventricular mass were indexed (LVMI) to height in grams/m2.7. LV remodeling was categorized as concentric remodeling (CR), concentric hypertrophy (CH), or eccentric hypertrophy based upon Echo- determined relative LV wall thickness.
Results:
Echo LVMI exceeded age-based normal values in 85% of subjects, and cMRI-determined LVMI correlated with depression of both diastolic and systolic tissue Doppler velocity (E': r = -0.65, P < .001, S': r = -0.46, P < .001) as well as increased early diastolic Doppler flow velocity/tissue velocity ratio (r= 0.55, P < .001), a marker of elevated LV filling pressure. Similar associations were found with echo-determined LV mass. Evidence of depressed LV relaxation and increased LV stiffness were observed in 88% and 71%, of subjects, respectively, despite a normal LV ejection fraction in almost all cases (mean = 60% + 7%). CR and CH were present in 40% and 44% of the study group, respectively, although significant depressions of E' and S' were observed only in subjects with CH (P < .005).
Conclusions:
A subclinical hypertrophic cardiomyopathy is common in pediatric FA patients and CH is associated with both diastolic and systolic dysfunction.
More Related Videos
08:22A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene
Published on: September 16, 2019
10:59Generation and Characterization of Human Induced Pluripotent Stem Cell-derived Astrocytes Lacking Fragile X Messenger Ribonucleoprotein
Published on: June 6, 2025
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy I: Introduction and Classification
